Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Multi-Year Registry Study of Elapegademase Treatment in Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Requiring Enzyme Replacement Therapy.
Journal: Journal of clinical immunology
Published: July 25, 2024
Treatment with Elapegademase Restores Immunity in Infants with Adenosine Deaminase Deficient Severe Combined Immunodeficiency.
Journal: Journal of clinical immunology
Published: January 05, 2024
Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open-label, single-arm, phase 3, and postmarketing clinical study.
Journal: Immunity, inflammation and disease
Published: November 10, 2022
Long-Term Immune Reconstitution in ADA-Deficient Patients Treated With Elapegademase: A Real-World Experience.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 03, 2022
Delayed-Onset ADA1 (ADA) Deficiency Not Detected by TREC Screen.
Journal: Pediatrics
Published: November 09, 2020
Single enzyme nanoparticle, an effective tool for enzyme replacement therapy.
Journal: Archives of pharmacal research
Published: October 30, 2019
Showing 1-6 of 6
Last Updated: 10/31/2025